tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

VRDN Stock Latest News

Viridian Therapeutics completes enrollment in THRIVE-2 trial
The FlyViridian Therapeutics completes enrollment in THRIVE-2 trial
2d ago
VRDN
Wedbush reveals three potential buyout targets for Biogen
PremiumThe Fly
Wedbush reveals three potential buyout targets for Biogen
11d ago
BIIB
EWTX
Viridian Therapeutics Releases Updated Investor Presentation
PremiumCompany Announcements
Viridian Therapeutics Releases Updated Investor Presentation
12d ago
8K
VRDN
Viridian Therapeutics’ Shareholders Approve Equity Plan Expansion
PremiumCompany Announcements
Viridian Therapeutics’ Shareholders Approve Equity Plan Expansion
1M ago
8K
VRDN
Viridian Therapeutics updates VRDN-003 Phase 3 program in thyroid eye disease
PremiumThe Fly
Viridian Therapeutics updates VRDN-003 Phase 3 program in thyroid eye disease
2M ago
VRDN
Viridian Therapeutics initiated with an Outperform at Wolfe Research
PremiumThe FlyViridian Therapeutics initiated with an Outperform at Wolfe Research
2M ago
AMGN
VRDN
Viridian Therapeutics initiated with a Buy at Goldman Sachs
PremiumThe Fly
Viridian Therapeutics initiated with a Buy at Goldman Sachs
2M ago
VRDN
Viridian Therapeutics price target lowered to $31 from $36 at Oppenheimer
PremiumThe Fly
Viridian Therapeutics price target lowered to $31 from $36 at Oppenheimer
3M ago
VRDN
Viridian Therapeutics downgraded to Neutral from Buy at Ladenburg
PremiumThe Fly
Viridian Therapeutics downgraded to Neutral from Buy at Ladenburg
3M ago
VRDN
Viridian Therapeutics price target lowered to $27 from $37 at H.C. Wainwright
PremiumThe Fly
Viridian Therapeutics price target lowered to $27 from $37 at H.C. Wainwright
3M ago
VRDN
Viridian Therapeutics downgraded to Neutral from Buy at B. Riley
PremiumThe Fly
Viridian Therapeutics downgraded to Neutral from Buy at B. Riley
3M ago
VRDN
Viridian Therapeutics reports Q1 EPS (79c), consensus ($1.10)
PremiumThe Fly
Viridian Therapeutics reports Q1 EPS (79c), consensus ($1.10)
3M ago
VRDN
Foghorn Therapeutics appoints Humer as Chief Financial Officer
PremiumThe FlyFoghorn Therapeutics appoints Humer as Chief Financial Officer
3M ago
FHTX
VRDN
Viridian Therapeutics price target lowered to $25 from $29 at B. Riley
PremiumThe Fly
Viridian Therapeutics price target lowered to $25 from $29 at B. Riley
4M ago
SLRN
VRDN
Viridian Therapeutics, Inc. (VRDN) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Viridian Therapeutics, Inc. (VRDN) Q4 Earnings Cheat Sheet
5M ago
VRDN
Viridian Therapeutics price target lowered to $37 from $39 at Wells Fargo
PremiumThe Fly
Viridian Therapeutics price target lowered to $37 from $39 at Wells Fargo
5M ago
SLRN
VRDN
Viridian Therapeutics price target raised to $40 from $39 at Wedbush
PremiumThe Fly
Viridian Therapeutics price target raised to $40 from $39 at Wedbush
5M ago
VRDN
Viridian Therapeutics price target lowered to $37 from $38 at JMP Securities
PremiumThe Fly
Viridian Therapeutics price target lowered to $37 from $38 at JMP Securities
5M ago
VRDN
Viridian Therapeutics expects cash to fund operations into second half of 2026
PremiumThe Fly
Viridian Therapeutics expects cash to fund operations into second half of 2026
5M ago
VRDN
Viridian Therapeutics reports Q4 EPS ($1.35), consensus ($1.00)
PremiumThe FlyViridian Therapeutics reports Q4 EPS ($1.35), consensus ($1.00)
5M ago
VRDN
Viridian Therapeutics names Jennifer Tousignant chief legal officer
PremiumThe Fly
Viridian Therapeutics names Jennifer Tousignant chief legal officer
5M ago
SANA
VRDN
Insider Trading: Viridian (NASDAQ:VRDN) Sees Huge Insider Buy
PremiumMarket News
Insider Trading: Viridian (NASDAQ:VRDN) Sees Huge Insider Buy
6M ago
VRDN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >